 |
|
 |
|
A warm welcome to Robert Ramirez, DO (pictured left) and Hagen Kennecke, MD (pictured right) on their new appointments in Tennessee and Oregon, respectively. READ MORE
| |
NANETS Offers Free, Virtual NET Patient Education Programs in May and June
| |
The North American Neuroendocrine Tumor Society, NANETS is offering free, virtual NET Patient Programs in conjunction with their regional medical education conferences. NET patients can participate in interactive programs with experts in the NET field. NANETS Virtual Regional Patient Programs are highly interactive, visually rich learning environments accessible from your computer, tablet, or mobile phone. READ MORE and REGISTER
| |
Detectnet Included in NCCN Guidelines® for Neuroendocrine Tumors
| |
The newest FDA-approved PET imaging agent for neuroendocrine tumors — DetectnetTM (copper Cu 64 Dotate injection) — is now included in the National Comprehensive Cancer Network® (NCCN) Clinical Practice Guidelines in Oncology – Neuroendocrine and Adrenal Tumors, version 1.2021. The announcement was made by RadioMedix Inc. and its commercial partner, Curium, on May 5. Detectnet is a positron emission tomography (PET) agent indicated for the localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults. READ MORE
| |
Ferrari Maserati Long Island’s Annual Rally to Red Tomato Artisanal Pizza on May 16 to Honor Eileen “Red” Bildman and Support the Carcinoid Cancer Foundation
| |
When Eileen “Red” Bildman was diagnosed with neuroendocrine cancer in 2017 little did she know how her life was going to change. It took her well over 10 years and numerous visits to many different specialty physicians, including gastroenterologists, a cardiologist, and an endocrinologist, before she was properly diagnosed. But that diagnosis did not hold her back from pursuing a dream to become a Ferrari race car driver at the age of 58.
| |
On Sunday, May 16, the Ferrari Maserati Long Island’s Rally to Red Tomato Artisanal Pizza 2021 will honor Eileen for her success in winning the 2020 Ferrari Challenge North America Ladies Cup during the Finale at Misano World Circuit held in Misano, Italy. Eileen has selected the Carcinoid Cancer Foundation as her charity of choice to be featured at the Rally. READ MORE
| |
HUTCHMED and NDA Submission to FDA for Treatment of Advanced Neuroendocrine Tumors
| |
HUTCHMED recently announced that it completed the rolling submission of a New Drug Application, NDA, to the U.S. Food and Drug Administration for surufatinib for the treatment of pancreatic and non-pancreatic neuroendocrine tumors. The drug has already launched in China and this is HUTCHMED’s first NDA submission in the United States. READ MORE
| |
Celebrating all of the wonderful nurses who work with patients in the neuroendocrine tumor community. Happy National Nurses Week (May 6-12)! And recognizing an ER nurse in Las Vegas who battled COVID-19, was diagnosed with lung neuroendocrine cancer, had his right lung removed, and then developed pneumonia following his surgery. Thank you, Elary Martinez, for being a frontline hero! READ MORE
| |
NJ Program Offering Free Rides to COVID-19 Vaccination Sites
| |
Are you a resident of New Jersey who needs assistance getting to and from a vaccination site? NJ Transit has a new public-private partnership offering New Jersey residents complimentary rides to and from vaccination sites. The “VAXRIDE” program is funded through the generosity of sponsors led by Novartis and provides for approximately 11,000 NJ residents to receive up to two, free round trips to get vaccinated. READ MORE
| |
|
|
|
The Carcinoid Cancer Foundation's educational, awareness and advocacy activities are made possible by your contributions. These crucial activities lead toward early detection, improving the quality of life for cancer survivors, and ultimately to a cure. The Carcinoid Cancer Foundation is a 501(c)(3) nonprofit organization. All contributions to the Carcinoid Cancer Foundation are tax-deductible to the extent allowed by law. Thank you for your support.
|
 |
Carcinoid Cancer Foundation
118 North Bedford Road, Suite 100
Mt. Kisco, NY 10549
888.722.3132
carcinoid@carcinoid.org
|
|
|
|
